We are delighted to share a new #podcast, “Improving the status quo – can severe asthma be better treated?” on @The Spectator Briefings!

We are delighted to share a new #podcast, “Improving the status quo – can severe asthma be better treated?” on @The Spectator Briefings!

We chat about the experiences of Gabby Perry, a student with severe #asthma, and the dual-edged swords that are steroids. Along with Gabby, Syed Ali, medical affairs manager at AstraZeneca, and OPRI’s own Professor David Price take us through the patient experience in consuming steroids, the cost of prescribing steroids for NHS, alternative treatments such as biologics, and the role of #ISAR in understanding #severeasthma.

This podcast was sponsored by @AstraZeneca.

Check out the podcast through this link: https://www.spectator.co.uk/podcast/can-severe-asthma-be-better-treated. (Also available on podcast distribution services such as Player FM.)